Gentex to acquire VOXX in $7.50 per share cash deal

Published 18/12/2024, 15:06
Gentex to acquire VOXX in $7.50 per share cash deal

This news is based on a press release statement and contains forward-looking statements which are subject to risks and uncertainties. The actual results could differ materially from those described due to a variety of factors. For a comprehensive analysis of Gentex (NASDAQ:GNTX)'s financial health and growth potential, investors can access detailed Pro Research Reports and additional financial metrics through InvestingPro, which currently shows the company trading at a P/E ratio of 15.93x and indicates potential upside based on its Fair Value assessment. For a comprehensive analysis of Gentex's financial health and growth potential, investors can access detailed Pro Research Reports and additional financial metrics through InvestingPro, which currently shows the company trading at a P/E ratio of 15.93x and indicates potential upside based on its Fair Value assessment.

The merger, unanimously recommended by VOXX's Transaction (JO:TCPJ) Committee, which is comprised of independent directors, and approved by both companies' Boards of Directors, represents a strategic expansion for Gentex. VOXX's portfolio includes automotive OEM and aftermarket business, as well as consumer electronics. The acquisition will grant Gentex full access to EyeLock® iris biometric technology, which Gentex plans to integrate into its automotive, aerospace, and medical market products.

Additionally, the acquisition includes the Premium Audio Company, home to premium audio brands such as Klipsch®, Onkyo®, and Integra®. Gentex aims to leverage its manufacturing expertise to aid Premium Audio's expansion in consumer technology and connected home spaces.

This news is based on a press release statement and contains forward-looking statements which are subject to risks and uncertainties. The actual results could differ materially from those described due to a variety of factors. For a comprehensive analysis of Gentex's financial health and growth potential, investors can access detailed Pro Research Reports and additional financial metrics through InvestingPro, which currently shows the company trading at a P/E ratio of 15.93x and indicates potential upside based on its Fair Value assessment.

The expected pro-forma annual EBITDA contribution from the acquisition is projected to be between $40 million and $50 million, following the execution of profitability improvement measures. Furthermore, Gentex foresees post-closing tax benefits of approximately $15 to $20 million related to tax loss and credit carryforwards.

Gentex believes that the acquisition will enhance its long-term growth, profitability, and shareholder value by expanding into new markets and harnessing acquired technologies. Legal counsel for the transaction is provided by Jones Day and financial advice by Acropolis Advisors for Gentex, while Solomon Partners and Bryan Cave Leighton Paisner LLP are advising VOXX's Transaction Committee.

This news is based on a press release statement and contains forward-looking statements which are subject to risks and uncertainties. The actual results could differ materially from those described due to a variety of factors.

In other recent news, Gentex Corporation, a key player in digital vision and connected car technologies, reported a rise in net sales and net income for Q3 2024, despite a global decline in light vehicle production. Net sales increased to $608.5 million from $575.8 million in Q3 2023, while net income rose by 17% to $122.5 million, boosting earnings per share up to $0.53. In the face of a 5% drop in global light vehicle production, Gentex managed to outperform underlying production numbers by 12% in Q3.

Baird maintained its Outperform rating on Gentex, following the company's third-quarter results which surpassed negative expectations. Baird highlighted the company's efforts to constrain operating expenses growth and its resumption of gross margin improvement as key factors for future trading support.

Beyond its automotive endeavors, Gentex made its first entry into the medical devices sector with sales totaling $0.8 million. CEO Steve Downing confirmed a strategic investment in Volkswagen (ETR:VOWG_p) and announced nine new product launches in the FDM segment. These recent developments indicate a diversification in Gentex's strategic investments and product offerings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.